Antitumor agents 278. 4-Amino-2H-benzo[h]chromen-2-one (ABO) analogs as potent in vitro anti-cancer agents
- PMID: 20542429
- PMCID: PMC2917187
- DOI: 10.1016/j.bmcl.2010.05.079
Antitumor agents 278. 4-Amino-2H-benzo[h]chromen-2-one (ABO) analogs as potent in vitro anti-cancer agents
Abstract
4-Amino-2H-benzo[h]chromen-2-one (ABO) analogs were designed, synthesized, and evaluated for cytotoxic activity. Among all 4-substituted ABO analogs, cyclohexyl (12), N-methoxy-N-methylacetamide (14), and various aromatic derivatives (15-25 and 27) exhibited promising cell growth inhibitory activity with ED(50) values of 0.01-5.8 microM against all tested tumor cell lines. The 4'-methoxyphenyl derivative (18) and 3'-methylphenyl derivative (24) showed the most potent antitumor activity against a broad range of cancer cell lines with ED(50) values of 0.01-76 microM. Preliminary SAR results indicated that substitutions on nitrogen are critical to the antitumor potency.
2010 Elsevier Ltd. All rights reserved.
Figures



Similar articles
-
Antitumor agents 281. Design, synthesis, and biological activity of substituted 4-amino-7,8,9,10-tetrahydro-2H-benzo[h]chromen-2-one analogs (ATBO) as potent in vitro anticancer agents.Bioorg Med Chem Lett. 2011 Jan 1;21(1):546-9. doi: 10.1016/j.bmcl.2010.10.074. Epub 2010 Nov 17. Bioorg Med Chem Lett. 2011. PMID: 21087859 Free PMC article.
-
Antitumor agents. 289. Design, synthesis, and anti-breast cancer activity in vivo of 4-amino-2H-benzo[h]chromen-2-one and 4-amino-7,8,9,10-tetrahydro-2H-benzo[h]chromen-2-one analogues with improved water solubility.J Nat Prod. 2012 Mar 23;75(3):370-7. doi: 10.1021/np2007878. Epub 2012 Feb 3. J Nat Prod. 2012. PMID: 22304236 Free PMC article.
-
Design, synthesis, biological evaluation and molecular docking studies of novel 3-aryl-4-anilino-2H-chromen-2-one derivatives targeting ERα as anti-breast cancer agents.Bioorg Med Chem Lett. 2017 Jun 15;27(12):2668-2673. doi: 10.1016/j.bmcl.2017.04.029. Epub 2017 Apr 12. Bioorg Med Chem Lett. 2017. PMID: 28460819
-
Synthesis and SAR studies of bis-chromenone derivatives for anti-proliferative activity against human cancer cells.Bioorg Med Chem Lett. 2014 Nov 15;24(22):5256-9. doi: 10.1016/j.bmcl.2014.09.057. Epub 2014 Sep 28. Bioorg Med Chem Lett. 2014. PMID: 25442319
-
Synthesis, biological evaluation and molecular docking of 4-Amino-2H-benzo[h]chromen-2-one (ABO) analogs containing the piperazine moiety.Bioorg Med Chem. 2019 Oct 15;27(20):115081. doi: 10.1016/j.bmc.2019.115081. Epub 2019 Aug 28. Bioorg Med Chem. 2019. PMID: 31493989
Cited by
-
Antitumor agents 287. Substituted 4-amino-2H-pyran-2-one (APO) analogs reveal a new scaffold from neo-tanshinlactone with in vitro anticancer activity.Bioorg Med Chem Lett. 2011 Apr 15;21(8):2341-4. doi: 10.1016/j.bmcl.2011.02.084. Epub 2011 Mar 21. Bioorg Med Chem Lett. 2011. PMID: 21420855 Free PMC article.
-
Antitumor agents 281. Design, synthesis, and biological activity of substituted 4-amino-7,8,9,10-tetrahydro-2H-benzo[h]chromen-2-one analogs (ATBO) as potent in vitro anticancer agents.Bioorg Med Chem Lett. 2011 Jan 1;21(1):546-9. doi: 10.1016/j.bmcl.2010.10.074. Epub 2010 Nov 17. Bioorg Med Chem Lett. 2011. PMID: 21087859 Free PMC article.
-
Recent Progress of Research on Herbal Products Used in Traditional Chinese Medicine: the Herbs belonging to The Divine Husbandman's Herbal Foundation Canon ( Shén Nóng Běn Cǎo Jīng).J Tradit Complement Med. 2012 Jan;2(1):6-26. doi: 10.1016/s2225-4110(16)30066-9. J Tradit Complement Med. 2012. PMID: 24716110 Free PMC article. Review.
-
Antitumor agents. 289. Design, synthesis, and anti-breast cancer activity in vivo of 4-amino-2H-benzo[h]chromen-2-one and 4-amino-7,8,9,10-tetrahydro-2H-benzo[h]chromen-2-one analogues with improved water solubility.J Nat Prod. 2012 Mar 23;75(3):370-7. doi: 10.1021/np2007878. Epub 2012 Feb 3. J Nat Prod. 2012. PMID: 22304236 Free PMC article.
-
Synthesis and characterization of some new 4-hydroxy-coumarin derivatives.Molecules. 2014 Aug 7;19(8):11791-9. doi: 10.3390/molecules190811791. Molecules. 2014. PMID: 25105917 Free PMC article.
References
-
- Vuorelaa P, Leinonenb M, Saikkuc P, Tammelaa P, Rauhad JP, Wennberge T, Vuorela H. Curr. Med. Chem. 2004;11:1375. - PubMed
-
- Saklani A, Kutty SK. Drug Discov. Today. 2008;13:161. - PubMed
-
- Rishton GM. Am. J. Cardiol. 2008;101:43D. - PubMed
-
- Wang X, Bastow KF, Sun CM, Lin YL, Yu HJ, Don MJ, Wu TS, Nakamura S, Lee KH. J. Med. Chem. 2004;47:5816. - PubMed
-
- Wang X, Nakagawa-Goto K, Bastow KF, Don MJ, Lin YL, Wu TS, Lee KH. J. Med. Chem. 2006;49:5631. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous